Skip to main content
. 2020 May 19;10:8294. doi: 10.1038/s41598-020-65162-2

Figure 2.

Figure 2

Optimization of nanoparticle size, avidity, and drug diffusivity. (A) Progress of MADS in obtaining the optimal solution. (B) Trial points selected by MADS, where the color and size of the points correspond to the value of TD. The smallest point refers to the optimal solution of TD minimization problem (shown by the arrow).